LRI Investments’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
SI
CPC
KAS
GGI
FWCM
QCM
LRI Investments's NVS Position: Q2 2026 in Review
LRI Investments held its Novartis (NVS) position steady in Q2 2026 at 2,933 shares worth $460K. The position accounts for 0.04% of the portfolio, ranked #196.
LRI Investments first reported a position in NVS in Q1 2024 and has held it in 10 quarters since. The position peaked at $490K in Q3 2024. 717 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- LRI Investments held 2,933 shares of Novartis worth $460K as of Q2 2026.
- LRI Investments left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.04% of LRI Investments's portfolio in Q2 2026, its #196 holding.
- LRI Investments first reported a position in Novartis in Q1 2024 and has held it in 10 quarters since.
- LRI Investments's Novartis position peaked at $490K in Q3 2024.
- 717 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.